Malik Raheel Tariq Founding Chairman, Kyrgyzstan International University, NRZ (KIUNRZ), Kyrgyzstan
Address for correspondence: Atul Dwivedi, Senior Resident, Department of Orthopedics, Shree Nursing Home & Trauma Centre, Bareilly 243001, Uttar Pradesh, India E-mail: elementalboy2008@yahoo.com
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
Atul Dwivedi, Dibash Baral, Shweta Dwivedi, et al. Application of Nanotechnology and Stem Cell Therapy in Musculoskeletal Disorders: Short Commentary. Jr. Orth. Edu. 2024;10(2):63–66.
Timeline
Received : May 27, 2024
Accepted : July 12, 2024
Published : August 25, 2024
Abstract
Nanotechnology and stem cell therapy (SCT) have emerged as revolutionary approaches in musculoskeletal disorders, offering innovative solutions to complex disoders. Traditional orthopedic surgeries and pharmaceuticals often fall short in terms of long-term efficacy and recovery time. Nanotechnology and stem cell therapy present more advanced, targeted, and minimally invasive alternative approach. Nanotechnology involves the manipulation of materials at nanoscale to create systems that can deliver correct diagnosis, and treatment of musculoskeletal disorders. Nanomaterials, such as nanoparticles, nanotubes, and nanofibers, have depicted significant improvement and enhancement in bone regeration, drug delivery, and tissue repair. small size of nanoparticles allow them to integrate better with biological system, ensuring precision in delivering therapeutic agents to specific sites in order to minimizing their side effects. Interestigly, nanoscale scaffolds have been developed to promote bone and cartilage regeneration by mimicking the extracellular matrix (ECM) and supporting the growth of new tissues. On the other hand, SCT uses undifferentiated cells with the ability to transform in to specific types, offering significant role in the treatment of damaged tendons, cartilage and bones. These stem cells can be guided more effectively to the target areas with the combination of nanoparticles, increasing the success rate of treatments.
References
1. Kennedy, D. G., O’Mahony, A. M., Culligan, E. P., O’Driscoll, C. M., and Ryan, K. B.2022). Strategies to mitigate and treat orthopaedic device-associated infections. Antibiot.Basel) 11 (12), 1822. doi:10.3390/antibiotics11121822.
2. Mohamed, M., Borchard, G., and Jordan, O.2012). In situ forming implants for local chemotherapy and hyperthermia of bone tumors. J. drug Deliv. Sci. Technol. 22 (5),393–408. Doi: 10.1016/ s1773-2247(12)50066-3.
3. Andronescu, E., Ficai, M., Voicu, G., Ficai, D., Maganu, M., and Ficai, A.2010).Synthesis and characterization of collagen/hydroxyapatite: Magnetite composite material for bone cancer treatment. J. Mater. Sci. Mater. Med. 21, 2237–2242. doi:10.1007/s10856-010-4076-7.
4. Hu, Q., Chen, F., Li, B., and Shen, J.2006). Preparation of three-dimensional nanomagnetite/chitosan rod. Mater. Lett. 60 (3), 368–370. doi:10.1016/j.matlet.2005.08.062.
5. Wei, G., Jin, Q., Giannobile, W. V., and Ma, P. X.2006). Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J. Control Release 112 (1), 103–110. doi:10.1016/j. jconrel.2006.01.011.
6. Pleshko, N., Grande, D. A., and Myers, K. R.2012). Nanotechnology in orthopedics. J. Am. Acad. Orthop. Surg. 20 (1), 60–62. doi:10.5435/00124635-201201000-00008.
7. Liao, J., Han, R., Wu, Y., and Qian, Z.2021). Review of a new bone tumor therapy strategy based on bifunctional biomaterials. Bone Res. 9 (1), 18. doi:10.1038/s41413-021-00139-z.
8. Sullivan, M. P., McHale, K. J., Parvizi, J., and Mehta, S.2014). Nanotechnology: Current concepts in orthopaedic surgery and future directions. Bone Jt. J. 96-b (5), 569–573. doi:10.1302/0301-620x.96b5.33606
9. Dohnert, M. B., VenancioPossatoZeferinoZug noZugno, A. I., et al.2012). Gold nanoparticles and diclofenac diethylammonium administered by iontophoresis reduce inflammatory cytokines expression in Achilles tendinitis. Int. J. Nanomedicine 7, 1651–1657. doi:10.2147/ijn. s25164.
10. D’Antimo, C., Biggi, F., Borean, A., Di Fabio, S., and Pirola, I.2017). Combining a novel leucocyte–platelet-concentrated membrane and an injectable collagen scaffold in a single-step AMIC procedure to treat chondral lesions of the knee: A preliminary retrospective study. Eur. J. Orthop. Surg. Traumatology 27, 673–681.
11. Garimella, R., and Eltorai, A. E.2017). Nanotechnology in orthopedics. J. Orthop. 14 (1), 30–33.
12. Mohanty, S., Yerneni, K., Theruvath, J. L., Graef, C. M., Nejadnik, H., Lenkov, O., et al. 2019). Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma. Cell Death Dis. 10 (2), 36.
13. Sykova, E., and Jendelova, P.2007). In vivo tracking of stem cells in brain and spinal cord injury. Prog. Brain Res. 161, 367–383.
14. Kyrtatos PG, Lehtolainen P, Junemann- Ramirez M et al. Magnetic tagging increases delivery of circulating progenitors in vascular injury. JACC Cardiovasc.Interv.2009; 2: 794-802.
15. Ho VHB, Barcza A, Chen R, et al. The precise control of cell labeling with streptavidin paramagnetic particles. Biomaterials. 2009; 30:6548-6555.
16. Kim J, Lee H, Kang H-j, et al.The targeting of endothelial progenitor cells to a specific location within a micro fluidic channel using magnetic nanoparticles. Biomed Microdevices.2009; 11:287-296.
17. Hsio JK, Tai MF, Chu HH. et al. Magnetic nanoparticle labeling of mesenchymal stem cells without transfection agent : cellular behaviour and capability of detection with clinical 1.5 T magnetic resonance at the single cell level. Magn Reson Med. 2007 ;58 :717-724.
18. Wilhelm C, Bal L, Smirnov P et al. Magnetic control of vascular network formation with magnetically labelled endothelial progenitor cells.Biomaterials.2007;28:3797-3806.
19. h t t p : / / w w w . m a y o c l i n i c . o r g / t e s t s - procedures/bone- marrow-transplant / indepth / stem-cells/art-20048117 access on 1 /9/2024.
20. Lindvall O,Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006 : 29;441(7097):1094-6.
21. Atul Dwivedi, SS Dwivedi, MR Tariq, et al. Conservative Treatment of Traumatic Lower Back Pain: Case Report and Literature Review. Journal of Clinical & Experimental Orthopaedics. 2019;(5)2:68
22. Dwivedi A, Dwivedi SS, Tariq MR, et al. Stem cell regenerative medicine -A new hope in orthopedics - Review Article. J Stem Cell Biol Transplant 2019; 3:1-4.
23. Dwivedi A, Dwivedi SS, Su Zhenhong et al. Open reduction and internal fixation of posterior pilon variant fractures with Butteress plate through a posterolateral approach. Int J Contemporary Med Res 2018; 5:1-5
24. Dwivedi A, WX Jian, Dwivedi SS, et al. Artificial cervical disc replacement, “A double edged sword” - A clinical review. Int J Contemporary Med Res 2017; 4:1163-1168
25. Dwivedi A, WX Jian, Dwivedi SS, et al. Pilon fracture: An unsolved riddle An updated review. Int J Contemporary Med Res 2017; 4:718-725
26. Dwivedi A, Dwivedi S, Issue of Heterotopic ossification in Artificial Cervical Disc Replacement. Int J of Emerging Technologies and Innovative Research 2024:11:2; 476-489
27. Sakai D, Mochida J, Iwashina T, et al. Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model; potential and limitation for stem cell therapy in disc regeneration. Spine 2005; 30:2379-2387
28. Dwivedi A, Dwivedi SS, Tariq MR, et al. A General Idea About the Reach of Stem Cell Regenerative Medicine: Evidence-Based Review. JRMDS, 2020:8(4); 57-64
29. García E, Sánchez-Noriega S, González-Pacheco G, González-Vázquez AN, Ibarra A, RodríguezBarrera R. Recent advances in the combination of cellular therapy with stem cells and nanoparticles after a spinal cord injury. Front Neurol. 2023 Apr 26; 14:1127878.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Atul Dwivedi, Dibash Baral, Shweta Dwivedi, et al. Application of Nanotechnology and Stem Cell Therapy in Musculoskeletal Disorders: Short Commentary. Jr. Orth. Edu. 2024;10(2):63–66.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.
This license enables
reusers to distribute, remix, adapt, and build upon the material in any medium
or format for noncommercial purposes only, and only so long as attribution is
given to the creator.